Results 191 to 200 of about 39,809 (306)

Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: Protective efficacy and long-term immunogenicity [PDF]

, 1997
Del Canho, R. (R.), Fetter, W.P.F. (Willem), Gast, G.C. (Gijsbert) de, Gerards, L.J. (L.), Grosheide, P.M. (Pia Maria), Heijtink, R.A. (Rudolf), Hop, W.C.J. (Wim), Mazel, J.A. (Jan), Schalm, S.W. (Solko), Zwijneberg, J. (J.)   +9 more
core   +3 more sources

Innovations in Gastric Cancer Surgery During Early Minimally Invasive Era and Future Perspectives

Annals of Gastroenterological Surgery, EarlyView.
With continuing revelations in tumor biology and the emergence of artificial intelligence, new horizons for surgical innovation are opening. At the center of this transformative journey stands the innovative surgeon, driven by passion, guided by data, and steadfast in the commitment to patient safety and quality of life.
Reut El‐On, Young‐Woo Kim
wiley   +1 more source

Baseline Hepatitis B Surface Antibody (Anti-HBs) Titers in Healthcare Workers at a Tertiary Care Center in Chennai, India. [PDF]

Cureus
Konda V, Vijayaraghavan S.
europepmc   +1 more source

Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus. [PDF]

Vaccines (Basel), 2021
Cocchio S, Baldo V, Volpin A, Fonzo M, Floreani A, Furlan P, Mason P, Trevisan A, Scapellato ML.   +8 more
europepmc   +1 more source

Natural History of Chronic Kidney Disease in Sickle Cell Disease

American Journal of Hematology, EarlyView.
ABSTRACT Kidney complications, referred to as nephropathy, develop early in sickle cell disease (SCD). In addition to its known morbidity, abundant data show that chronic kidney disease (CKD) is associated with an increased mortality risk in SCD. Increasing evidence suggests that the natural history of SCD nephropathy is progressive. Initial glomerular
Kenneth I. Ataga
wiley   +1 more source

Anti-HBs Seroprevalence in Blood Donors from Tyrol, Austria. [PDF]

Vaccines (Basel)
Seekircher L, Mühlbacher A, Tschiderer L, Wachter GA, Astl M, Schennach H, Siller A, Willeit P.   +7 more
europepmc   +1 more source

Post vaccination antibody titres of hepatitis B surface antigen (anti-HBs) in a mixed cohort of health care workers. [PDF]

Med J Armed Forces India, 2022
Lall M, Sen S, Patrikar S, Karade S, Gupta RM.   +4 more
europepmc   +1 more source

Effects of folic acid supplementation before conception on innate immunity and anti-HBs levels of offspring born to HBsAg-positive mothers. [PDF]

Front Nutr
Lian J, Men Z, Xu X, Li Y, Li J, Wang W, Yao T, Li Y, Qu Y, Feng Y, Wang S.   +10 more
europepmc   +1 more source

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real‐World International Experience

American Journal of Hematology, EarlyView.
ABSTRACT Sutimlimab is a monoclonal antibody against complement fraction C1s approved for the treatment of hemolytic anemia due to cold agglutinin disease (CAD). Here, we analyzed and report the largest international CAD cohort of sutimlimab‐treated patients ever reported to highlight its safety and effectiveness in the real‐world setting. We accrued a
Bruno Fattizzo, Elisa Sambruna, Yoshitaka Miyakawa, Marc Michel, Carlo Visco, Michael Fillitz, George Kannourakis, Maria Bruna Greve, Moritz Kleemiss, Johan Cid, Andrea Patriarca, Laura Pavan, Arbana Dizdari, Nilla Maschio, Antonella Sau, Cinzia Bitetti, Riccardo Mario Colombo, Luigi Curreli, Dorela Lame, Uros Markovic, Fabrizio Pappagallo, Giacinto Luca Pedone, Davide Rapezzi, Vincenzo Sammartano, Nicola Tumedei, Antonio Giovanni Solimando, Jalink Marit, Luana Fianchi, Jahanzaib Khwaja, Antonio De Vivo, Francesco Lanza, Fabrizio Vianello, Esther N. Oliva, Catherine Broome, Francesco Passamonti, Ulrich Jaeger, Bernd Jilma, Guillaume Moulis, Wilma Barcellini   +38 more
wiley   +1 more source

Investigation of Hepatitis B Virus (HBsAg, Anti-HBs) and Anti-Hepatitis C Virus Serology in Erzurum Region: 2015-2023. [PDF]

Eurasian J Med
Uçar M, Yılmaz A, Çelebi D, Çelebi Ö.   +3 more
europepmc   +1 more source